Pharmacy Networks Become Access Infrastructure for Latin American Healthcare

Integrated pharmacy network services in Latin America are gaining stronger relevance as payers, providers and employers look for more organized ways to connect patients with medicines, pharmacists and follow-up support. The category is no longer limited to pharmacy contracting or reimbursement administration. It is becoming a healthcare access model that links retail pharmacies, digital prescriptions, medication programs and benefit management.

Grand View Research expects the Latin America pharmacy benefit management market to grow at a 10 percent CAGR from 2025 to 2033, while noting that the region accounted for 2.6 percent of the global PBM market in 2024. That growth reflects rising demand for structured prescription-drug programs, network management and cost-control services.

This matters because access to medicine in Latin America is often fragmented. Patients may move between public clinics, private doctors, retail pharmacies and insurer networks without a consistent medication record. Integrated pharmacy network providers can reduce that fragmentation by connecting pharmacy availability, benefit rules, adherence support and claims data.

The retail pharmacy base has also been evolving. According to Credence Research, chain pharmacies had the largest share of the Latin America retail pharmacy market in 2024, owing to their extensive network and high level of operational efficiency. Similarly, the retail market coverage mentions online pharmacy development through e-commerce portals and increasing store openings in Brazil.

For integrated network providers, this creates a practical opportunity. Large pharmacy chains can provide reach, while digital tools can support eligibility checks, prescription routing, inventory visibility and patient communication. A strong network does not simply list pharmacies. It coordinates where a patient can receive the right medication under the right benefit rules.

Mexico shows the complexity of the market. FEMSA’s 2025 annual filing said the pharmacy services market in Mexico is highly fragmented, including national chains, regional chains, independent pharmacies, supermarkets and informal neighborhood drugstores. It also said FEMSA’s Health Division relies on a robust logistics network based on an integrated view of the supply chain.

Such fragmentation complicates the task of designing an appropriate network. The payer and employer both desire maximum accessibility as well as the necessary quality criteria, dispensing control and data collection capabilities. If too many weakly linked outlets exist within the network, then visibility or adherence enhancement becomes unattainable.

Integrated pharmacy network services can also support chronic care. Patients with diabetes, hypertension or cardiovascular conditions often need repeat prescriptions, refill reminders and pharmacist counseling. A network that can identify missed refills or duplicate therapies can help improve continuity.

The challenge is balancing access and standardization. Latin America’s markets differ in regulation, pharmacy practice and digital maturity. A model that works in Brazil may need adaptation in Colombia, Mexico or Peru.

The next phase of pharmacy network services in Latin America will likely favor providers that combine reach with data discipline. Coverage alone will not be enough.

Integrated pharmacy network services in Latin America are becoming a medication-access infrastructure. Their value will be measured by whether they help payers and providers improve access, control costs and support better medication continuity across fragmented healthcare systems.